Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 97,052
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12618065 | MiRNA detargeting system for tissue specific interference | 🖼🧊📄§ | 2026-05-05 | 2038-10-02 | 0 | 31 |
| 12618066 | Promoter having high activity in activated T-cell | 🖼🧊📄§ | 2026-05-05 | 2040-11-13 | 0 | 31 |
| 12618076 | Methods of engineering platelets for targeting circulating tumor cells | 🖼🧊📄§ | 2026-05-05 | 2040-09-30 | 0 | 31 |
| 12618082 | Engineered muscle targeting compositions | 🖼🧊📄§ | 2026-05-05 | 2042-03-29 | 0 | 31 |
| 12617762 | Carboxy derivatives with antiinflamatory properties | 🖼🧊📄§ | 2026-05-05 | 2040-12-23 | 0 | 31 |
| 12617790 | Mitragynine analogs and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-06-24 | 0 | 31 |
| 12617805 | Codrug that disintegrates in intestine, preparation therefor, and use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-07-19 | 0 | 31 |
| 12617807 | Long lasting opioid reversal using hydrogen peroxide-induced release in blood | 🖼🧊📄§ | 2026-05-05 | 2042-04-01 | 0 | 31 |
| 12617809 | Cardioprotective lipid and method of use | 🖼🧊📄§ | 2026-05-05 | 2042-09-22 | 0 | 31 |
| 12617811 | HPK1 inhibitors and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-07-02 | 0 | 31 |
| 12617812 | Platinum(IV) complexes, methods of manufacture, compositions containing, and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2042-05-25 | 0 | 31 |
| 12617820 | Engineered coronavirus spike (s) protein and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-05-28 | 0 | 31 |
| 12617822 | Arc-based capsids and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2042-10-13 | 0 | 31 |
| 12617826 | CLEC2 fusion protein and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-09-29 | 0 | 31 |
| 12617828 | Genetically modified immune cell, preparation method therefor, and application | 🖼🧊📄§ | 2026-05-05 | 2040-05-06 | 0 | 31 |
| 12617831 | Peptide targeting GIP and GLP-2 receptors for treating bone disorders | 🖼🧊📄§ | 2026-05-05 | 2040-02-21 | 0 | 31 |
| 12617833 | Tethered interleukin-15 and interleukin-21 | 🖼🧊📄§ | 2026-05-05 | 2039-02-07 | 0 | 31 |
| 12617832 | Genetic engineering of B cell receptors and uses thereof in antigen-induced antibody secretion | 🖼🧊📄§ | 2026-05-05 | 2041-03-12 | 0 | 31 |
| 12617836 | Tumor environment specific expression of effector genes | 🖼🧊📄§ | 2026-05-05 | 2042-03-21 | 0 | 31 |
| 12617837 | Composition for use in treatment of allergic diseases | 🖼🧊📄§ | 2026-05-05 | 2040-02-28 | 0 | 31 |
| 12617839 | Factor VIII chimeric proteins and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-11-05 | 0 | 31 |
| 12617841 | Nucleic acid antibody constructs for use against respiratory syncytial virus | 🖼🧊📄§ | 2026-05-05 | 2039-01-31 | 0 | 31 |
| 12617850 | Treatment of PD-L1-positive melanoma using an anti-PD-1 antibody | 🖼🧊📄§ | 2026-05-05 | 2042-03-22 | 0 | 31 |
| 12617849 | Antigen specific CD19-targeted CAR-T cells | 🖼🧊📄§ | 2026-05-05 | 2040-04-29 | 0 | 31 |
| 12617851 | TREM2 antibodies and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2042-05-05 | 0 | 31 |
| 12617856 | Protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2045-03-17 | 0 | 31 |
| 12617864 | Methods of activating and proliferating exhausted CD8 T cells, CD8 T cells with enhanced activity prepared by the same, and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2042-04-12 | 0 | 31 |
| 12617866 | Humanized antibodies to mucin-16 and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2040-05-07 | 0 | 31 |
| 12617867 | Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof | 🖼🧊📄§ | 2026-05-05 | 2039-09-25 | 0 | 31 |
| 12617868 | Activation of (Na++K+)-ATPase inhibits platelet aggregation and prevents thrombosis | 🖼🧊📄§ | 2026-05-05 | 2042-11-08 | 0 | 31 |
| 12617870 | Methods of reversing ticagrelor activity | 🖼🧊📄§ | 2026-05-05 | 2039-09-20 | 0 | 31 |
| 12617873 | Method of purifying polysaccharides | 🖼🧊📄§ | 2026-05-05 | 2040-11-30 | 0 | 31 |
| 12617887 | Resin composition for stereolithography | 🖼🧊📄§ | 2026-05-05 | 2041-02-09 | 0 | 31 |
| 12617903 | Process for producing a composition comprising a crosslinked hydrogel | 🖼🧊📄§ | 2026-05-05 | 2040-12-08 | 0 | 31 |
| 12618074 | CD40 specific DNA aptamers as vaccine adjuvants | 🖼🧊📄§ | 2026-05-05 | 2040-04-13 | 0 | 31 |
| 12618031 | Delivery devices | 🖼🧊📄§ | 2026-05-05 | 2041-06-24 | 0 | 31 |
| 12618048 | Dual CAR-T cells | 🖼🧊📄§ | 2026-05-05 | 2041-07-30 | 0 | 31 |
| 12617772 | Hydroxypyridine HSD17B13 inhibitors and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2042-04-04 | 0 | 31 |
| 12617773 | Azetidin-3-ylmethanol derivatives as CCR6 receptor modulators | 🖼🧊📄§ | 2026-05-05 | 2041-04-30 | 0 | 31 |
| 12617774 | Substituted indole compounds and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2045-05-30 | 0 | 31 |
| 12617799 | Pyrazolopyrimidinone compounds | 🖼🧊📄§ | 2026-05-05 | 2042-03-25 | 0 | 31 |
| 12617853 | Low pH pharmaceutical composition comprising T cell engaging antibody constructs | 🖼🧊📄§ | 2026-05-05 | 2038-02-02 | 0 | 31 |
| 12617854 | Humanized or chimeric CD3 antibodies | 🖼🧊📄§ | 2026-05-05 | 2042-05-09 | 0 | 31 |
| 12616755 | Antifungal quercetin conjugates, methods of preparation and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2045-10-08 | 0 | 31 |
| 12616652 | Lenses for treating ocular diseases and preparation method thereof | 🖼🧊📄§ | 2026-05-05 | 2042-12-29 | 0 | 31 |
| 12616745 | Influenza virus backbone | 🖼🧊📄§ | 2026-05-05 | 2040-06-05 | 0 | 31 |
| 12616733 | XBP1, CD138, and CS1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions | 🖼🧊📄§ | 2026-05-05 | 2041-02-10 | 0 | 31 |
| 12616714 | Enhanced oligonucleotides for modulating FUBP1 expression | 🖼🧊📄§ | 2026-05-05 | 2041-06-25 | 0 | 31 |
| 12616749 | Methods for treatment of psoriasis with an anti-oxLDL antibody | 🖼🧊📄§ | 2026-05-05 | 2044-06-21 | 0 | 31 |
| 12616685 | Concomitant administration of glucocorticoid receptor modulator relacorilant and CYP2C9 substrates | 🖼🧊📄§ | 2026-05-05 | 2041-05-26 | 0 | 31 |
Page 1Next →